电话:
+86 (0512) 65829739
传真:
+86 (010) 6788 5057
电子邮件:
orders@antibodies-online.cn

Recombinant PCSK9 (Bococizumab Biosimilar) 抗体

The Human 单克隆 anti-PCSK9 (Bococizumab Biosimilar) antibody is suitable to detect PCSK9 (Bococizumab Biosimilar) in samples from 人. It has been validated for FACS, ELISA, BLI, Func 和 SPR.
产品编号 ABIN7675911
发货至: 中国
Contact our Customer Service for availability and price in your country. Contact Info

Our Local Distributor

中国
北京 101111
No. 88 KeChuang 6th Street
Beijing Economic Technological Development Area
Room 801-803
4A Biotech Co.,Ltd.
Tel +86 (0512) 65829739 传真 +86 (010) 6788 5057

Quick Overview for Recombinant PCSK9 (Bococizumab Biosimilar) 抗体 (ABIN7675911)

抗原

PCSK9 (Bococizumab Biosimilar)

抗体类型

Recombinant Antibody

适用

宿主

  • 3
  • 1
Human

克隆类型

  • 3
  • 1
单克隆

标记

  • 3
  • 1
This PCSK9 (Bococizumab Biosimilar) antibody is un-conjugated

应用范围

Flow Cytometry (FACS), ELISA, Bio-Layer Interferometry (BLI), Functional Studies (Func), Surface Plasmon Resonance (SPR)
  • Expression System

    CHO Cells

    原理

    Anti-PCSK9 Reference Antibody (bococizumab)

    序列

    QVQLVQSGAE VKKPGASVKV SCKASGYTFT SYYMHWVRQA PGQGLEWMGE ISPFGGRTNY NEKFKSRVTM TRDTSTSTVY MELSSLRSED TAVYYCARER PLYASDLWGQ GTTVTVSSAS TKGPSVFPLA PCSRSTSEST AALGCLVKDY FPEPVTVSWN SGALTSGVHT FPAVLQSSGL YSLSSVVTVP SSNFGTQTYT CNVDHKPSNT KVDKTVERKC CVECPPCPAP PVAGPSVFLF PPKPKDTLMI SRTPEVTCVV VDVSHEDPEV QFNWYVDGVE VHNAKTKPRE EQFNSTFRVV SVLTVVHQDW LNGKEYKCKV SNKGLPSSIE KTISKTKGQP REPQVYTLPP SREEMTKNQV SLTCLVKGFY PSDIAVEWES NGQPENNYKT TPPMLDSDGS FFLYSKLTVD KSRWQQGNVF SCSVMHEALH NHYTQKSLSL SPGK,DIQMTQSPSS LSASVGDRVT ITCRASQGIS SALAWYQQKP GKAPKLLIYS ASYRYTGVPS RFSGSGSGTD FTFTISSLQP EDIATYYCQQ RYSLWRTFGQ GTKLEIKRTV AAPSVFIFPP SDEQLKSGTA SVVCLLNNFY PREAKVQWKV DNALQSGNSQ ESVTEQDSKD STYSLSSTLT LSKADYEKHK VYACEVTHQG LSSPVTKSFN RGEC

    产品特性

    Anti-PCSK9 Reference Antibody (bococizumab) is expressed from CHO. The heavy chain type is huIgG2, and the light chain type is hukappa. It has a predicted MW of 145.5 kDa.

    纯度

    >95 %

    亚型

    IgG2SA
  • 应用备注

    Optimal working dilution should be determined by the investigator.

    说明

    Therapeutic Agents by Target and Mechanism: PCSK9 inhibitors

    限制

    仅限研究用
  • 状态

    Lyophilized

    浓度

    1 mg/mL

    缓冲液

    25 mM histidine, 8 % sucrose, 0.01 % Tween80 pH 6.2

    储存条件

    4 °C,-80 °C

    储存方法

    +4°C,-80°C
  • 抗原

    PCSK9 (Bococizumab Biosimilar)

    物质类

    Biosimilar

    分子量

    145.5 kDa

    UniProt

    Q8NBP7
You are here: